Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
Tamo 20 tablets may pose a serious risk to your health and should not be taken.
Tamo 20 tablets are not related to the approved medicine Tamoxifen Citrate.
- The tablets contain the substance tamoxifen at a strength lower than that described on the bottle.
The supply of Tamo 20 tablets is illegal as they are considered to be counterfeit.
Tamo 20 tablets have not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA..
TGA investigations have shown that a number of people in Australia may have bought the product online.
Information for consumers
- Stop taking Tamo 20 tablets and take any remaining tablets to your local pharmacy for safe disposal.
- If you have any concerns arising from your use of this product, consult your health care practitioner.
Action the TGA is taking
The TGA is working with the Australian Border Force (ABF) to help stop future shipments of Tamo 20 tablets from entering Australia.
If these tablets are found at the border by the ABF they will be seized and destroyed.
The TGA is advising consumers to exercise extreme caution when purchasing medicines from unknown overseas Internet sites and has produced a short video on the risks associated with buying medicines and medical devices online. Products purchased over the Internet:
- may contain undisclosed and potentially harmful ingredients
- may not meet the same standards of quality, safety and efficacy as those approved by the TGA for supply in Australia.